CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019
-
12 01 2021
-
-
Source: Drug Alcohol Depend. 229(Pt A):109160
[PDF-727.14 KB]
Details:
-
Alternative Title:Drug Alcohol Depend
-
Personal Author:
-
Description:Background:
Deaths involving illicitly manufactured fentanyl (IMF) have increased since 2013 in the United States. Little research has examined individuals using IMF. This study aims to explore the characteristics of US adults who used IMF, heroin, or misused prescription opioids and examine the associations between demographic, clinical, psychosocial characteristics and IMF use.
Methods:
A convenience sample of adults aged ≥ 18 years being assessed for substance use disorder (SUD) treatment was collected between January-December 2019 using the Addiction Severity Index-Multimedia Version instrument. We used a multivariable logistic regression model to examine the associations between demographic, clinical, psychosocial characteristics and IMF use.
Results:
Adults reporting IMF as their primary lifetime substance use problem also reported using other substances—most often alcohol or heroin—both in the past 30 days and during their lifetime. Characteristics associated with increased odds of reporting IMF as the primary lifetime substance use problem included age 18–24 years (adjusted odds ratio (aOR) = 1.68; 95% confidence interval (CI) = 1.18–2.38) versus 45–54 years, non-Hispanic Black persons (aOR = 1.44; 95% CI = 1.11–1.85) versus non-Hispanic White persons, being assessed in Northeast (aOR = 15.46; 95% CI = 8.67–27.56) versus West, and having a history of at least one lifetime overdose (1 overdose (aOR = 1.91; 95% CI = 1.49–2.44); 2 overdoses (aOR = 1.95; 95% CI = 1.48–2.58); 3 or more overdoses (aOR = 2.27; 95% CI = 1.82–2.82)).
Conclusions:
These findings provide new insights into this high-risk population and help identify strategies to address increasing overdose death rates involving IMF. Opportunities for intervention include expanding naloxone distribution and harm reduction programs and connecting individuals with nonfatal overdoses to SUD treatment.
-
Subjects:
-
Source:
-
Pubmed ID:34740067
-
Pubmed Central ID:PMC8671312
-
Document Type:
-
Funding:
-
Place as Subject:
-
Volume:229
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
